Drug Pricing Bill with Medicaid Component Moves Forward in SenateImage Banner

Drug Pricing Bill with Medicaid Component Moves Forward in Senate

You are here

Drug Pricing Bill with Medicaid Component Moves Forward in Senate

Monday, July 29, 2019
Categories: 

ANCOR is sharing this article by Politico Pro in case some of our members purchase medications through Medicaid as part of the supports they offer to people with disabilities.

As written by Politico Pro:

“The Senate Finance Committee today voted 19-9 to send an overhaul of Medicare and Medicaid drug payments to the chamber's floor, advancing a long-awaited effort from bipartisan leadership.

The Congressional Budget Office estimated that the proposal would save taxpayers $100 billion over 10 years through both Medicare and Medicaid changes.

All the no votes were Republicans, many of whom opposed inflation caps in Part D.

[…]

Wyden told reporters that he won't pass the bill unless he gets votes on giving Medicare negotiating power and protecting people with preexisting conditions. ‘And I'm sure Republicans are going to talk about areas that they're concerned about,’ he said. Several Republicans have voiced concerns that Part D inflation caps would drive up prices.”